logo
The Science Behind IV Therapy: How It Works and What to Expect

The Science Behind IV Therapy: How It Works and What to Expect

Introduction
IV Therapy is becoming more popular than ever, and people are turning to this treatment to feel better, faster. But how does it work? Why is it different from taking medicine by mouth or drinking water for hydration? In this article, we'll explore the science behind IV Therapy, how it helps your body, and what you can expect if you try it. This treatment may sound like something only used in hospitals, but it's also used in wellness centers and even at home. Let's dive into this fascinating health tool and learn how it could support your well-being.
How IV Therapy Works in the Body
IV Therapy, short for intravenous therapy, works by delivering fluids, vitamins, or medications straight into your bloodstream through a vein. This is different from swallowing a pill or drinking water because those methods must first pass through your digestive system. With IV Therapy, nutrients go directly into your blood, so your body can use them immediately. This makes the treatment fast and effective, especially for people who are dehydrated, low on vitamins, or recovering from illness.
When something is given through a vein, it doesn't get broken down in the stomach or liver. That means more of the good stuff reaches your cells. This method is especially helpful if you have a medical condition that prevents your body from absorbing nutrients properly. Doctors have used IV Therapy for many years in hospitals to help patients get better, but now it's also used outside hospitals for general wellness.
Benefits of IV Therapy for Health and Wellness
There are many reasons people try IV Therapy. One of the biggest benefits is hydration. If someone is very dehydrated—maybe from being sick, exercising too much, or being out in the heat—IV Therapy can help rehydrate them quickly. It also helps with things like vitamin deficiencies. Sometimes, people don't get enough vitamins from their food or have trouble absorbing them. IV drips can include vitamins like B12, C, and others to support energy, immunity, and overall health.
Some IV drips are designed to help with recovery after workouts, stress, jet lag, or even a hangover. People who receive IV treatments often report feeling more awake, alert, and refreshed soon after. Some clinics also offer IV drips to help support skin health, metabolism, or even mental clarity. While it's not magic, IV Therapy is based on science, and its quick results are one reason why it's becoming so popular.
What Happens During an IV Therapy Session
When you go in for an IV Therapy session, the process is usually simple and relaxing. A nurse or trained technician will first ask about your health and what you're hoping to achieve with the treatment. Then, they'll insert a small needle into a vein, often in your arm. This needle is attached to a thin tube connected to a bag filled with fluids. This bag hangs from a stand, and gravity helps the fluids flow slowly into your bloodstream.
The whole session usually takes 30 to 60 minutes. You'll be able to sit back in a comfy chair, sometimes with a blanket, and relax while the therapy takes place. Some people bring a book, scroll on their phone, or just close their eyes. You may feel a cool sensation where the fluid enters, but it shouldn't be painful. After the session, most people feel energized and hydrated. You don't need to rest or recover afterward—many go right back to their daily routine.
Different Types of IV Therapy Treatments
Not all IV Therapy is the same. Different blends of fluids and nutrients can be used for different needs. Some are made for athletes who need to rehydrate and replace minerals after a tough workout. Others are designed to give a boost to your immune system, especially during cold and flu season. There are also drips that include antioxidants, which help fight free radicals in the body. Some people use these as part of a skincare routine to help brighten the skin and improve how it looks and feels.
Doctors may also use IV Therapy for more serious health issues. For example, patients who are fighting infections, have certain chronic diseases, or are going through cancer treatment may need IV medications or nutrients. Some therapies include iron for people with anemia, while others may include treatments for migraines or pain. Because IV treatments go straight into the bloodstream, doctors can make sure the right amount of medicine gets where it's needed fast.
Is IV Therapy Safe? Things to Know Before You Try
Just like with any health treatment, it's important to understand the risks and make sure it's done safely. IV Therapy is generally very safe when done by trained professionals. Clinics should always use clean, sterile tools, and check your medical history before giving you a drip. You should never get IV treatments from someone without proper training or in an unclean environment. That's why it's important to visit a licensed clinic or have a certified professional come to your home.
Some people may feel slight side effects, like feeling cold during the drip or getting a little bruise where the needle went in. Serious side effects are rare but can happen, such as infections, allergic reactions, or swelling if the IV is not placed properly. That's why it's important to talk with your doctor or healthcare provider before starting IV Therapy, especially if you have a medical condition. Make sure to ask questions and share your health history to stay safe and get the most benefit from the treatment.
Conclusion
IV Therapy is a powerful way to deliver hydration, nutrients, and medications directly into your body. It works faster than pills or drinks and can help with a wide range of issues—from fatigue to illness recovery. As more people look for ways to stay healthy and feel their best, IV treatments are becoming a helpful tool. Whether you're trying to bounce back from the flu or just want an energy boost, IV drips offer real benefits backed by science. Always make sure to get treatments from professionals and talk to your doctor to see if IV Therapy is right for you. The science behind this therapy is simple but effective, and it's helping people of all ages feel stronger and healthier every day.
TIME BUSINESS NEWS

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Regenxbio's Gene Therapy Helps Kids with Deadly Muscle Disease
Regenxbio's Gene Therapy Helps Kids with Deadly Muscle Disease

Bloomberg

time2 hours ago

  • Bloomberg

Regenxbio's Gene Therapy Helps Kids with Deadly Muscle Disease

Children with a deadly muscle disorder had more control of their bodies after getting an experimental gene therapy from Regenxbio Inc. in a small study. The results foreshadow a potential rivalry with Sarepta Therapeutics Inc. and a critical test for the Trump administration's new drug regulators. The first five children with Duchenne muscular dystrophy to receive a higher dose of Regenxbio's treatment showed 'consistent benefit' after nine months, with improvements in motor function and the time it took to stand, walk and climb, the company said Thursday. It's conducting a larger study involving about 30 patients that it expects to be in full swing by the end of the year, with the potential to file for approval by mid-2026.

Local Pride center: ‘We need to move from pride flags to policy change'
Local Pride center: ‘We need to move from pride flags to policy change'

Yahoo

time14 hours ago

  • Yahoo

Local Pride center: ‘We need to move from pride flags to policy change'

SAVANNAH, Ga. (WSAV)– The Savannah Pride Center offers year-round therapy, support groups and help with medical care for their community. The center's executive director Micheal Bell told WSAV that pride is all about becoming stronger as a community but he said this year there is more work than ever. 'We have the fastest growing new HIV cases in the country,' Bell said. 'We are one of the lowest in health care and we have a huge, vibrant, diverse LGBTQ+ population. The work is there to do but we also have to remember to celebrate that diversity.' Recently the Savannah Pride Center announced a new partnership with the Savannah Police Department. The police and the center developed a relationship after one of the Savannah Pride Center volunteers was murdered. 'With the police department, we have an opportunity to train the police on pronouns, history and culture with the LGBTQ+ community,' Bell Said 'This is the biggest step forward that our community has taken to protect our LGBTQ+ community here in Savannah.' The Savannah Pride Center will host an event on June 28 at Starland Yard to honor the history of the Stonewall Uprising. They emphasize that pride is ultimately about coming together and being stronger as a community. The city of Savannah recognizes June and October as Pride Months due to June being the start of hurricane season. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Yahoo

time16 hours ago

  • Yahoo

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

LOS ANGELES, June 04, 2025--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on June 2, 2025, the Compensation Committee of Puma's Board of Directors approved the grant of inducement restricted stock unit awards covering 18,250 shares of Puma common stock to three new non-executive employees. The awards were granted under Puma's 2017 Employment Inducement Incentive Award Plan, which was adopted on April 27, 2017 and provides for the granting of equity awards to new employees of Puma. The restricted stock unit awards vest over a three-year period, with one-third of the shares underlying the award vesting on the first anniversary of the award's vesting commencement date, June 1, 2025, and one-sixth of the shares underlying the award vesting on each six-month anniversary of the vesting commencement date thereafter, subject to continued service. The awards were granted as an inducement material to the new employees entering into employment with Puma, in accordance with Nasdaq Listing Rule 5635(c)(4). About Puma Biotechnology Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral) in 2011. Neratinib, oral was approved by the U.S. Food and Drug Administration in 2017 for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, following adjuvant trastuzumab-based therapy, and is marketed in the United States as NERLYNX® (neratinib) tablets. In February 2020, NERLYNX was also approved by the FDA in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. NERLYNX was granted marketing authorization by the European Commission in 2018 for the extended adjuvant treatment of adult patients with early stage hormone receptor-positive HER2-overexpressed/amplified breast cancer and who are less than one year from completion of prior adjuvant trastuzumab-based therapy. NERLYNX® is a registered trademark of Puma Biotechnology, Inc. In September 2022, Puma entered into an exclusive license agreement for the development and commercialization of the anti-cancer drug alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Initially, Puma intends to focus the development of alisertib on the treatment of small cell lung cancer and breast cancer. In February 2024, Puma initiated ALISCA™-Lung1, a Phase II clinical trial of alisertib monotherapy for the treatment of patients with extensive-stage small cell lung cancer. In November 2024, Puma initiated ALISCA™-Breast1, a Phase II clinical trial of alisertib in combination with endocrine therapy for the treatment of patients with HER2-negative, HR-positive metastatic breast cancer. View source version on Contacts Alan H. Auerbach or Mariann Ohanesian, Puma Biotechnology, Inc., +1 424 248 6500info@ ir@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store